LigaChem Biosciences Inc. (KOSDAQ:141080)

LigaChem Biosciences Revenue

LigaChem Biosciences had revenue of 35.89B KRW in the quarter ending March 31, 2026, a decrease of -30.42%. This brings the company's revenue in the last twelve months to 125.87B, down -14.04% year-over-year. In the year 2025, LigaChem Biosciences had annual revenue of 141.55B with 12.43% growth.

• Revenue (ttm): 125.87B
• Revenue Growth: -14.04%
• P/S Ratio: 43.24
• Revenue / Employee: 740.39M
• Employees: 170
• Market Cap: 5.44T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	141.55B	15.65B	12.43%
Dec 31, 2024	125.90B	91.75B	268.71%
Dec 31, 2023	34.15B	733.60M	2.20%
Dec 31, 2022	33.41B	1.26B	3.90%
Dec 31, 2021	32.16B	-25.34B	-44.07%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 3, 2026

Data Sources Report a data error